— Know what they know.
Not Investment Advice
Also trades as: AVCN.TO (TSX) · $vol 0M

AVCNF OTC

Avicanna Inc.
1W: -4.4% 1M: -17.5% 3M: -13.9% YTD: -56.1% 1Y: -61.0% 3Y: -63.3% 5Y: -89.8%
$0.07
+0.00 (+1.18%)
 
Weekly Expected Move ±15.4%
$0 $0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 38 · $8.9M mcap · 97M float · 0.095% daily turnover · Short 58% of daily vol

Income Trends

Revenue
$25M +51.6% ▲
5Y CAGR: +172.9%
Gross Profit
$13M +93.7% ▲
5Y CAGR: +168.7%
Operating Income
-$5M +41.0% ▲
Net Income
-$4M +58.6% ▲
EPS (Diluted)
$-0.04 +63.8% ▲
EBITDA
-$2M +67.0% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$2M$3M$4M$17M$25M
YoY Growth+833.2%+108.2%+23.8%+314.8%+51.6%
Cost of Revenue$2M$437K$3M$10M$13M
Gross Profit-$570K$3M$1M$7M$13M
Gross Margin-36.3%86.6%27.6%39.7%50.7%
R&D Expenses$376K$304K$277K$331K$178K
SG&A Expenses$16M$13M$10M$14M$16M
Operating Expenses$18M$14M$12M$15M$18M
Operating Income-$19M-$11M-$11M-$8M-$5M
Operating Margin-1180.4%-331.4%-261.3%-47.2%-18.4%
Interest Expense$263K$738K$2M$610K$334K
Income Before Tax-$35M-$17M-$15M-$9M-$4M
Tax Expense-$2M$14K$0$0$0
Net Income-$33M-$17M-$15M-$9M-$4M
Net Margin-2093.0%-513.2%-364.0%-52.1%-14.2%
EPS (Diluted)$-1.12$-0.41$-0.25$-0.10$-0.04
EBITDA-$17M-$15M-$12M-$7M-$2M
Shares Outstanding29M41M59M85M100M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms